Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 5,635,655 | 4,383,900 | 2,950,354 | 1,398,395 | 5,187,168 |
| Depreciation Amortization | 474,480 | 311,550 | 203,698 | 92,290 | 440,299 |
| Accounts receivable | -705,701 | N/A | N/A | N/A | -363,667 |
| Accounts payable and accrued liabilities | 161,082 | N/A | N/A | N/A | -3,422 |
| Other Working Capital | 53,347 | -527,700 | -169,672 | -524,453 | -263,525 |
| Other Operating Activity | 1,560,597 | 1,406,400 | 353,167 | 139,321 | 700,252 |
| Operating Cash Flow | $7,179,460 | $5,574,150 | $3,337,547 | $1,105,552 | $5,697,105 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 306,710 | 304,350 | 306,686 | N/A | 223,200 |
| PPE Investments | -1,049,265 | -683,850 | -421,523 | -161,359 | -775,099 |
| Net Acquisitions | N/A | N/A | N/A | N/A | 342,686 |
| Purchase Of Investment | -75,489 | -94,500 | -80,659 | -72,471 | -527,050 |
| Sale Of Investment | -16,643 | 2,400 | 152 | N/A | 4,762 |
| Purchase Sale Intangibles | -178,171 | -141,150 | -18,380 | -7,395 | -175,882 |
| Other Investing Activity | -174,307 | -137,250 | -14,582 | -3,698 | -175,882 |
| Investing Cash Flow | $-1,008,994 | $-608,850 | $-209,926 | $-237,527 | $-907,382 |
| Cash Flows From Financing Activities | |||||
| Common Stock Repurchased | -2,237,470 | -1,644,300 | -1,118,440 | -555,365 | -2,558,765 |
| Dividend Paid | -3,541,138 | -3,574,500 | -2,465,337 | -2,400,417 | -1,920,264 |
| Other Financing Activity | 0 | 0 | 0 | 415,747 | 0 |
| Financing Cash Flow | $-5,778,608 | $-5,218,800 | $-3,583,777 | $-2,540,035 | $-4,479,029 |
| Exchange Rate Effect | -3,864 | -11,850 | -13,063 | -19,671 | 12,797 |
| Beginning Cash Position | 2,355,310 | 2,377,500 | 2,407,615 | 2,344,215 | 2,034,989 |
| End Cash Position | 2,743,305 | 2,112,150 | 1,938,396 | 652,535 | 2,358,480 |
| Net Cash Flow | $387,995 | $-265,350 | $-469,219 | $-1,691,680 | $323,491 |
| Free Cash Flow | |||||
| Operating Cash Flow | 7,179,460 | 5,574,150 | 3,337,547 | 1,105,552 | 5,697,105 |
| Capital Expenditure | -1,050,305 | -684,150 | -421,674 | -161,359 | -777,331 |
| Free Cash Flow | 6,129,155 | 4,890,000 | 2,915,873 | 944,193 | 4,919,774 |